A new editorial paper titled "Targeting ABC transporters in PDAC—past, present, or future?" has been published in Oncotarget. In this new editorial, Cecilia Bergonzini, Elisa Giovannetti and Erik H.J.
“[...] it is crucial for the future application of ABC transporter inhibitors [...] to develop a stratification protocol [...] to identify those PDAC patients who ...
MDR3 defects are involved in the development of PFIC3, LPAC, ICP, and DILI. Sterolin 1/2 are cotransporters that transport plant sterols and can lead to sitosterolemia if mutated. MRP2 is responsible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results